J. Goldman & CO LP Beyond Air, Inc. Transaction History

J. Goldman & CO LP

  • $3.27 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$5.9 - $12.54 $91,461 - $194,395
-15,502 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$5.13 - $7.24 $79,525 - $112,234
15,502 New
15,502 $85,000
Q1 2020

May 15, 2020
SELL
$3.94 - $10.93 $421,473 - $1.17 Million
-106,973 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$3.57 - $5.23 $153,606 - $225,031
-43,027 Reduced 28.68%
106,973 $559,000
Q3 2019

Nov 14, 2019
BUY
$4.17 - $5.89 $625,500 - $883,500
150,000 New
150,000 $690,000

Others Institutions Holding XAIR

# of Institutions
64
Shares Held
11.1M
Call Options Held
54.4K
Put Options Held
7K
View Full List

About Beyond Air, Inc.

XAIR Quotes by TradingView
  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $17M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email